Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia

Arquivos de Neuro-Psiquiatria

Volumn 65, Issue 3 B, 2007, Pages 803-809

  De Almeida, Sérgio Monteiro ^a   Nanakanishi, Edna ^a   De Conto, Arnaldo J ^a   Souza, Luciana P ^a   Antonelli Filho, Dario ^a   Roda, Carlos D ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Central nervous system; Cerebrospinal fluid; CNS neoplasm; CNS tumors; Malignant cells

Indexed keywords

GLUCOSE; PROTEIN; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BREAST CANCER; CELL COUNT; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID CYTOLOGY; CHEMICAL ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EWING SARCOMA; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEURILEMOMA; PROSTATE CANCER; RETINOBLASTOMA; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; STOMACH CANCER; CEREBROSPINAL FLUID; CHEMISTRY; CYTOLOGY; LONGITUDINAL STUDY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADOLESCENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 35448945106     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2.Ed. Philadelphia: WB Saunders, 1992..
2. Browne TJ, Goumnerova LC, De Girolami U, et al. Cytologic features of piloctic astrocytoma in cerebrospinal fluid specimens. Acta Cytol 2004;48:3-8.
3. Glosova L, Dundr P, Effler J, et al. Gallbladder carcinoma cells in cerebrospinal fluid as the first manifestation of a tumor: a case report. Acta Cytol 2003;47:1087-1090.
4. Livramento JA, Machado LR, Clemente HAM, Tabares-Olives A, Spina-França A. Melanomatose meningea: análise citomorfologica do líquido cefalorraqueano. Arq Neuropsiquiatr 1979;37:7-14.
5. Moraes-Rêgo SF, Moraes-Rêgo KG. Exame citológico do líquido céfalo-raquidiano no diagnóstico de neoplasias primitivas ou metastáticas do sistema nervoso. Arq Neuropsiquiatr 1986;44:165-173.
6. Rolim JAB, Barsottini OGP, Prado GF, Nakandakare F, Reis MLAA, Reis-Filho JB. Líquido cefalorraquidiano no diagnóstico de metástase cérebro-meníngea de melanoma maligno derivado de nevo melanocítico gigante congênito. Arq Neuropsiquiatr 1996;54:479-483
7. Bossolasco S, Nilsson A, Milito A, et al. Soluble CD23 in cerebrospinal fluid: a marker of AIDS related non-Hodgkin's lymphoma in the brain. AIDS 2001;15:1109-1113.
8. Murare S, Saio M, Takenaka K, et al. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma. Cancer Lett 1998;132:181-186.
9. Kjeldsberg CR, Knight JA. Body fluids. Chicago: American Society of Clinical Pathologists, 1993:65-157.
10. De Luca A, Antinori A, Cingolani A, et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. British J Haematol 1995;90:844-849.
11. Sadler M, Brink NS, Gazzard BG. Management of intracerebral lesions in patients with HIV: a retrospective study with discussion of diagnostic problems. Q J Med 1998;91:205-217.
12. Van Oostenbrugge RJ, Twijnstra A. Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999;53: 382-385.
13. Balm M, Hammack J. Leptomeningeal carcinotasis: presenting features and prognostic factors. Arch Neurol 1996;53: 626-632.
14. Glass JP, Melamed M, Chernik NL, et al. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 1979;29:1369-1375.
15. Watson CW, Hajdu SI. Cytology of primary neoplasm of the central nervous system. Acta Cytol 1977;21:40-47.
16. Sá MJ, Vaz R, Cruz C. Cerebrospinal fluid cytomorphologic findings in 41 intracranial tumors. Arq Neuropsiquiatr 1995;53:218-226.
17. Rogers LR, Duchesneau PM, Nunez C, et al. Comparison of cisternal and lumbar CSF examination in leptomingeal metastasis. Neurology 1992;42:1239-1241.
18. Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 1998;82:733-739.
19. Spina-França A, Machado ABB, Pasqualin JR. Técnica de suta e identi-ficação de células neoplásicas no líquido cefalorraquidiano. Arq Neuropsiquiatr 1971;29:463-466.
20. De Reuck J, Vanderdonckt P, de Bleecker J, et al. Mitotic activity in cerebrospinal fluid cells. Clin Neurol Neurosurg 1988;90:117-119.
21. Lane PA, Githens JH. Contamination of cerebrospinal fluid with bonemarrow cells during lumbar puncture. N Engl J Med 1983;309:434-435.
22. Luban NLC, Alessi RM, Gold BG, et al. Cerebral spinal fluid pleocytosis with bone marrow contamination. J Pediatr 1984;104:254-256.
23. Mastrangelo R, Poplack D, Bleyer A, et al. Report and recommendations of the Rome Workshop concerning poor prognosis in acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 1986;14:191-194.
24. Aaronson AG, Hadju SI, Melamed MR. Spinal fluid cytology during chemotherapy of leukemia of the central nervous system in children. Am J Clin Pathol 1975;63:523-537.
25. Van Zanten AP, Twijnstra A, Ongerboer de Visser BW. Routine investigation of the CSF with special reference to meningeal malignancy and infectious meningitis. Acta Neurol Scand 1988;77:210-214.
26. Watson MA, Scott MG: Clinical utility of biochemical analysis of cerebrospinal fluid. Clin Chem 1995;41:343-360.
27. Faller DV, Mentzer SJ, Perrine SP: Induction of the Epstein-Barr virus tymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus associated malignancies. Curr Opin Oncol 2001;13:360-367.
28. Weller M, Stevens A, Sommer N, et al. Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia. Acta Neurol Scand 1992;86:129-133.
29. Kleine TO, Zwerenz P, Zofel P, et al. New and old diagnostic markers of meningitis in cerebrospinal fluid (CSF). Brain Research Bull 2003;61:287-297.
30. Hayward RA, Oye RK. Are polymorphonuclear leukocytes an abnormal finding in cerebrospinal? Results from 225 normal cerebrospinal fluid specimens. Arch Intern Med 1988;148:1623-1624.
31. Kim L, Glantz MJ. Neoplastic meningitis. Curr Treat Options Oncol 2001;2:517-527.
32. Freilich RJ, Krol G, De Angelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995;38:51-57.
33. Sampath P, Weaver CE, Sungarian A, et al. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (Recoverin) tumor markers for malignant glioma. Cancer Control 2004;11:174-180.
34. Hug A, Storch-Hagenlocher B, Haas J, et al. Single-cell PCR analysis of the immunoglobulin heavy-chain CDR3 region for the diagnosis of leptomeningeal involvement of B-cell malignancies using standard cerebrospinal fluid cytospins. J Neurol Sci 2004;219:83-88.